Tuesday, December 4, 2012- This Biotech Is a Train Wreckat Motley Fool (Tue, Dec 4)
- Geron skids after ending drug study, cutting jobsAP (Tue, Dec 4)
- Stocks to Watch: Oracle, Geron, Knight, Big Lots (Update 1)TheStreet (Tue, Dec 4)
- Morning Briefing: 10 Things You Should Knowat TheStreet (Tue, Dec 4)
- Geron Moves Up, Sucampo Wins FDA Approval to Discontinue Warnings: Health Care Business Updateat Wall St. Cheat Sheet (Tue, Dec 4)
Monday, December 3, 2012- Geron lays off 40, loses CFO after killing brain cancer drug trialsat bizjournals.com (Mon, Dec 3)
- Geron ends brain cancer drug study, cuts 43 jobsAP (Mon, Dec 3)
- Geron laying off 43 more, ending brain cancer drug programat bizjournals.com (Mon, Dec 3)
- After-Hours Buzz: ORCL, GERN & Moreat CNBC (Mon, Dec 3)
- Geron discontinues GRN1005, announces workforce reductionat theflyonthewall.com (Mon, Dec 3)
Saturday, December 1, 2012 Friday, November 23, 2012 Tuesday, November 20, 2012 Monday, November 19, 2012 Friday, November 16, 2012 Thursday, November 15, 2012 Thursday, November 8, 2012 Sunday, November 4, 2012 Friday, November 2, 2012 Thursday, November 1, 2012 Wednesday, October 31, 2012 Tuesday, October 30, 2012 Monday, October 29, 2012Add GERN News to My Yahoo!  | |
|